Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leiomyosarcoma × talimogene laherparepvec × Clear all

Sponsor

Conditions

Melanoma 8 Sarcoma 3 Neoplasm Metastasis 3 Triple Negative Breast Neoplasms 2 Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Rectal Neoplasms 1 Pleural Effusion, Malignant 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Inflammatory Breast Neoplasms 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma, Ductal, Breast 1 Carcinoma, Ductal 1 Advanced Non CNS Tumors 1 Adenocarcinoma 1

Interventions

Doxorubicin 6 pazopanib 4 Trabectedin 3 Sorafenib 3 Gemcitabine 3 Docetaxel 3 Dacarbazine 3 pembrolizumab 2 eribulin 2 Sunitinib 2 Radiotherapy, Conformal 2 Radiotherapy 2 Nivolumab 2 Letrozole 2 Ifosfamide 2 Bevacizumab 2 tremelimumab 1 temsirolimus 1 saracatinib 1 rucaparib 1 romidepsin 1 olaratumab 1 liposomal doxorubicin 1 lenvatinib 1 indolepropanol phosphate 1 durvalumab 1 cixutumumab 1 berzosertib 1 avelumab 1 Watchful Waiting 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡